Intensity Therapeutics Inc
NASDAQ:INTS 3:29:02 PM EDT
Intensity Therapeutics Inc Stock, NASDAQ:INTS
1 Enterprise Drive, Suite 430, Shelton, Connecticut 06880
United States of America
Phone: +1.203.221.7381
Number of Employees: 17
Description
Intensity Therapeutics, Inc. operates as biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.